Andrews, Nick

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 2,889

Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

Bernal, J. L., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 2,888

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Lopez Bernal, J., Andrews, N., Gower, C., Robertson, C., Stowe, J., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 1,389

Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England

Bernal, J. L., Andrews, N., Gower, C., Stowe, J., Robertson, C., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 1,389

Effectiveness of maternal pertussis vaccination in England: an observational study

Amirthalingam, G., Andrews, N., Campbell, H., Ribeiro, S., Kara, E., Donegan, K., Fry, N. K., Miller, E., & Ramsay, M. (2014) · The Lancet

Bacterial Infections and VaccinesVaccine Coverage and Hesitancy

Cited by 739

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · The Lancet

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 638

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet

Bacterial Infections and VaccinesMicrobial infections and disease research

Cited by 571

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

Andrews, N. J., Waight, P. A., Burbidge, P., Pearce, E., Roalfe, L., Zancolli, M., Slack, M., Ladhani, S. N., Miller, E., & Goldblatt, D. (2014) · The Lancet Infectious Diseases

Pneumonia and Respiratory InfectionsBacterial Infections and Vaccines

Cited by 545

A Statistical Algorithm for the Early Detection of Outbreaks of Infectious Disease

Farrington, C. P., Andrews, N. J., Beale, A. D., & Catchpole, M. A. (1996) · Journal of the Royal Statistical Society. Series A (Statistics in Society)

Data-Driven Disease SurveillanceAdvanced Statistical Process Monitoring

Cited by 417

Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction

Amirthalingam, G., Campbell, H., Ribeiro, S., Fry, N. K., Ramsay, M., Miller, E., & Andrews, N. (2016) · Clinical Infectious Diseases

Bacterial Infections and VaccinesDiphtheria, Corynebacterium, and Tetanus

Cited by 275

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

Parikh, S. R., Andrews, N. J., Beebeejaun, K., Campbell, H., Ribeiro, S., Ward, C., White, J. M., Borrow, R., Ramsay, M. E., & Ladhani, S. N. (2016) · The Lancet

Bacterial Infections and VaccinesNeonatal and Maternal Infections

Cited by 275

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England

Cohen, C., White, J. M., Savage, E. J., Glynn, J. R., Choi, Y., Andrews, N., Brown, D., & Ramsay, M. E. (2007) · Emerging infectious diseases

Virology and Viral DiseasesBacterial Infections and Vaccines

Cited by 241

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England

Kirsebom, F. C. M., Andrews, N., Stowe, J., Toffa, S., Sachdeva, R., Gallagher, E., Groves, N., O'Connell, A.-M., Chand, M., Ramsay, M., et al. (2022) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 182

Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator

Ladhani, S. N., Andrews, N. J., Southern, J., Jones, C. E., Amirthalingam, G., Waight, P. A., England, A., Matheson, M., Bai, X., Findlow, H., et al. (2015) · Clinical Infectious Diseases

Bacterial Infections and VaccinesDiphtheria, Corynebacterium, and Tetanus

Cited by 180

Estimating Haemophilus influenzae Type b Vaccine Effectiveness in England and Wales by Use of the Screening Method

Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases

Bacterial Infections and VaccinesPneumonia and Respiratory Infections

Cited by 172

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Stowe, J., Andrews, N., Kirsebom, F., Ramsay, M., & Bernal, J. L. (2022) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 166

Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study

Deasy, A. M., Guccione, E., Dale, A. P., Andrews, N., Evans, C. M., Bennett, J. S., Bratcher, H. B., Maiden, M. C. J., Gorringe, A. R., & Read, R. C. (2015) · Clinical Infectious Diseases

Bacterial Infections and VaccinesMicrobial infections and disease research

Cited by 125

Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization

Feikin, D. R., Abu-Raddad, L. J., Andrews, N., Davies, M.-A., Higdon, M. M., Orenstein, W. A., & Patel, M. K. (2022) · Vaccine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 83

Risk of serious neurologic disease after immunization of young children in Britain and Ireland

Ward, K. N., Bryant, N. J., Andrews, N. J., Bowley, J. S., Ohrling, A., Verity, C. M., Ross, E. M., & Miller, E. (2007) · PEDIATRICS

Pharmacovigilance and Adverse Drug ReactionsInfectious Encephalopathies and Encephalitis

Cited by 46

No evidence of an increase of bacterial and viral infections following measles, mumps and rubella vaccine

Stowe, J., Andrews, N., Taylor, B., & Miller, E. (2009) · Vaccine

Virology and Viral DiseasesImmune responses and vaccinations

Cited by 43

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization

Feikin, D. R., Higdon, M. M., Andrews, N., Collie, S., Deloria Knoll, M., Kwong, J. C., Link-Gelles, R., Pilishvili, T., & Patel, M. K. (2023) · Vaccine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 36

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England

Møller Kirsebom, F. C., Andrews, N., Stowe, J., Groves, N., Chand, M., Ramsay, M., & Bernal, J. L. (2022) · The Lancet Regional Health - Europe

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 31

Safety of COVID-19 vaccination and acute neurological events: a self-controlled case series in England using the OpenSAFELY platform

Walker, J. L., Schultze, A., Tazare, J., Tamborska, A., Singh, B., Donegan, K., Stowe, J., Morton, C. E., Hulme, W. J., Curtis, H. J., et al. (2022) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 30